Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2012

01-02-2012

Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44

Authors: Orly Shimony, Arnon Nagler, Yechiel N. Gellman, Efrat Refaeli, Nir Rosenblum, Lora Eshkar-Sebban, Ronit Yerushalmi, Avichai Shimoni, Simon D. Lytton, Anfisa Stanevsky, Reuven Or, David Naor

Published in: Journal of Clinical Immunology | Issue 1/2012

Login to get access

Abstract

We show here that the anti-T lymphocyte immunoglobulin (ATG) can induce Treg cells following 24-h incubation in human peripheral blood mononuclear cells (PBMCs). The ATG-induced Treg cells express known cell surface markers (e.g., CD25, FoxP3) and suppress the proliferation of autologous responder PBMCs, stimulated with allogeneic PBMCs, when added into the mixed lymphocyte culture (MLC) at zero time point or 48 h later. We expanded the characteristics of the ATG-induced human Treg cells by showing that they express a novel biomarker designated “activated CD44”. ATG-induced Treg cells retain their suppressor function after freezing and thawing or irradiation. Suppression of MLC by ATG-induced Treg cells is consistently seen when the Treg cells and the responder cells were derived from the same donor, but not when they derived from different donors. Finally, patients undergoing stem cell transplantation and conditioned with ATG generate in vivo Treg cells that suppress MLC.
Literature
1.
go back to reference Mothy M. Mechanism of action of antithymocyte globulin: T cell depletion and beyond. Leukemia. 2007;21:1387–94.CrossRef Mothy M. Mechanism of action of antithymocyte globulin: T cell depletion and beyond. Leukemia. 2007;21:1387–94.CrossRef
2.
go back to reference Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523–32.PubMedCrossRef Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523–32.PubMedCrossRef
3.
go back to reference Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+FoxP3+ regulatory T cells. J Am Soc Nephrol. 2006;17:2844–53.PubMedCrossRef Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+FoxP3+ regulatory T cells. J Am Soc Nephrol. 2006;17:2844–53.PubMedCrossRef
4.
go back to reference Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+. Blood. 2008;111:3675–83.PubMedCrossRef Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+. Blood. 2008;111:3675–83.PubMedCrossRef
5.
go back to reference Ruzek MC, Waire JS, Hopkins D, Lacorcia G, Sullivan J, Roberts BL, et al. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood. 2008;111:1726–34.PubMedCrossRef Ruzek MC, Waire JS, Hopkins D, Lacorcia G, Sullivan J, Roberts BL, et al. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood. 2008;111:1726–34.PubMedCrossRef
6.
go back to reference Broady R, Yu J, Levings MK. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. Blood. 2009;114:5003–6.PubMedCrossRef Broady R, Yu J, Levings MK. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. Blood. 2009;114:5003–6.PubMedCrossRef
7.
go back to reference Vogt Sionov R, Naor D. Hyaluronan-independent lodgement of CD44+ lymphoma cells in lymphoid organs. Int J Cancer. 1997;71:462–9.PubMedCrossRef Vogt Sionov R, Naor D. Hyaluronan-independent lodgement of CD44+ lymphoma cells in lymphoid organs. Int J Cancer. 1997;71:462–9.PubMedCrossRef
8.
go back to reference Naor D, Vogt Sionov R, Ish-Shalom D. CD44: structure, function and its association with the malignant process. Adv Cancer Res. 1997;71:241–319.PubMedCrossRef Naor D, Vogt Sionov R, Ish-Shalom D. CD44: structure, function and its association with the malignant process. Adv Cancer Res. 1997;71:241–319.PubMedCrossRef
9.
go back to reference Naor D, Nedvetzki S, Golan I, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci. 2002;39:527–79.PubMedCrossRef Naor D, Nedvetzki S, Golan I, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci. 2002;39:527–79.PubMedCrossRef
10.
go back to reference Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond L, et al. RHAMM, a receptor for hyaluronan-mediated motility compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci USA. 2004;101:18081–6.PubMedCrossRef Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond L, et al. RHAMM, a receptor for hyaluronan-mediated motility compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci USA. 2004;101:18081–6.PubMedCrossRef
11.
12.
go back to reference Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood. 2006;107:619–27.PubMedCrossRef Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood. 2006;107:619–27.PubMedCrossRef
13.
go back to reference Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight TN, et al. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol. 2007;179:744–7.PubMed Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight TN, et al. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol. 2007;179:744–7.PubMed
14.
go back to reference Liu T, Soong L, Liu G, König R, Chopra AK. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells. Biol Direct. 2009;4:40.PubMedCrossRef Liu T, Soong L, Liu G, König R, Chopra AK. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells. Biol Direct. 2009;4:40.PubMedCrossRef
15.
go back to reference Min B, Thornton A, Caucheteux SM, Younes SA, Oh K, Hu-Li J, et al. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol. 2007;37:1916–23.PubMedCrossRef Min B, Thornton A, Caucheteux SM, Younes SA, Oh K, Hu-Li J, et al. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol. 2007;37:1916–23.PubMedCrossRef
16.
go back to reference Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140:845–58.PubMedCrossRef Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140:845–58.PubMedCrossRef
17.
go back to reference Chung DT, Korn T, Richard J, Ruzek M, Kohm AP, Miller S, et al. Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expending myelin antigen-specific FoxPox3+ regulatory T cells. Int Immunol. 2007;19:1003–10.PubMedCrossRef Chung DT, Korn T, Richard J, Ruzek M, Kohm AP, Miller S, et al. Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expending myelin antigen-specific FoxPox3+ regulatory T cells. Int Immunol. 2007;19:1003–10.PubMedCrossRef
18.
go back to reference Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and IL-17 cells. Annu Rev Immunol. 2009;27:485–517.PubMedCrossRef Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and IL-17 cells. Annu Rev Immunol. 2009;27:485–517.PubMedCrossRef
19.
go back to reference Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L, Rosenblum N, et al. Regulatory T-cell in Graves’ orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011;96:422–9.PubMedCrossRef Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L, Rosenblum N, et al. Regulatory T-cell in Graves’ orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011;96:422–9.PubMedCrossRef
Metadata
Title
Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44
Authors
Orly Shimony
Arnon Nagler
Yechiel N. Gellman
Efrat Refaeli
Nir Rosenblum
Lora Eshkar-Sebban
Ronit Yerushalmi
Avichai Shimoni
Simon D. Lytton
Anfisa Stanevsky
Reuven Or
David Naor
Publication date
01-02-2012
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2012
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9599-2

Other articles of this Issue 1/2012

Journal of Clinical Immunology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.